TY - JOUR
T1 - Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice
AU - Conforti, Laura
AU - Wilbrey, Anna
AU - Morreale, Giacomo
AU - Janeckova, Lucie
AU - Beirowski, Bogdan
AU - Adalbert, Robert
AU - Mazzola, Francesca
AU - Stefano, Michele Di
AU - Hartley, Robert
AU - Babetto, Elisabetta
AU - Smith, Trevor
AU - Gilley, Jonathan
AU - Billington, Richard A.
AU - Genazzani, Armando A.
AU - Ribchester, Richard R.
AU - Magni, Giulio
AU - Coleman, Michael
PY - 2009/2/23
Y1 - 2009/2/23
N2 - The slow Wallerian degeneration (Wld S) protein protects injured axons from degeneration. This unusual chimeric protein fuses a 70 - amino acid N-terminal sequence from the Ube4b multiubiquitination factor with the nicotinamide adenine dinucleotide - synthesizing enzyme nicotinamide mononucleotide adenylyl transferase 1. The requirement for these components and the mechanism of Wld S -mediated neuroprotection remain highly controversial. The Ube4b domain is necessary for the protective phenotype in mice, but precisely which sequence is essential and why are unclear. Binding to the AAA adenosine triphosphatase valosin-containing protein (VCP)/p97 is the only known biochemical property of the Ube4b domain. Using an in vivo approach, we show that removing the VCP-binding sequence abolishes axon protection. Replacing the Wld S VCP-binding domain with an alternative ataxin-3 - derived VCP-binding sequence restores its protective function. Enzyme-dead Wld S is unable to delay Wallerian degeneration in mice. Thus, neither domain is effective without the function of the other. Wld S requires both of its components to protect axons from degeneration.
AB - The slow Wallerian degeneration (Wld S) protein protects injured axons from degeneration. This unusual chimeric protein fuses a 70 - amino acid N-terminal sequence from the Ube4b multiubiquitination factor with the nicotinamide adenine dinucleotide - synthesizing enzyme nicotinamide mononucleotide adenylyl transferase 1. The requirement for these components and the mechanism of Wld S -mediated neuroprotection remain highly controversial. The Ube4b domain is necessary for the protective phenotype in mice, but precisely which sequence is essential and why are unclear. Binding to the AAA adenosine triphosphatase valosin-containing protein (VCP)/p97 is the only known biochemical property of the Ube4b domain. Using an in vivo approach, we show that removing the VCP-binding sequence abolishes axon protection. Replacing the Wld S VCP-binding domain with an alternative ataxin-3 - derived VCP-binding sequence restores its protective function. Enzyme-dead Wld S is unable to delay Wallerian degeneration in mice. Thus, neither domain is effective without the function of the other. Wld S requires both of its components to protect axons from degeneration.
UR - http://www.scopus.com/inward/record.url?scp=61449113031&partnerID=8YFLogxK
U2 - 10.1083/jcb.200807175
DO - 10.1083/jcb.200807175
M3 - Article
SN - 0021-9525
VL - 184
SP - 491
EP - 500
JO - Journal of Cell Biology
JF - Journal of Cell Biology
IS - 4
ER -